vibostolimab
mAbexperimental
Clinical trial activity
14 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
13
Phase 3
5
Phase 4
0
Earliest trial started Dec 13, 2016 (NCT02964013)
Timeline
Indications
Studied for
- Carcinoma, Hepatocellular · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 3
- Carcinoma, Transitional Cell · Phase 1/Phase 2
- Cholangiocarcinoma · Phase 2
- Endometrial Neoplasms · Phase 2
- Esophageal Neoplasms · Phase 2
- Gallbladder Neoplasms · Phase 2
- Hematologic Neoplasms · Phase 2
- Lung Neoplasms · Phase 3
- Melanoma · Phase 3
- Neoplasms · Phase 1/Phase 2
- Ovarian Neoplasms · Phase 2
- Small Cell Lung Carcinoma · Phase 3
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Stomach Neoplasms · Phase 2
- Triple Negative Breast Neoplasms · Phase 2
- Urinary Bladder Neoplasms · Phase 2
- Uterine Cervical Neoplasms · Phase 2
Mechanism of action
T-cell immunoreceptor with Ig and ITIM domains antagonist
inhibitor - TIGIT
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297785 ↗
Also known as
- mk-7684
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05845814 | Phase 1/Phase 2 (Phase 2) | Jun 23, 2023 | Merck |
| NCT05665595 | Phase 3 | Jan 25, 2023 | Merck |
| NCT05298423 | Phase 3 | May 3, 2022 | Merck |
| NCT05224141 | Phase 3 | Mar 24, 2022 | Merck |
| NCT05226598 | Phase 3 | Mar 24, 2022 | Merck |
| NCT05005442 | Phase 2 | Sep 28, 2021 | Merck |
| NCT05007106 | Phase 2 | Sep 16, 2021 | Merck |
| NCT04725188 | Phase 2 | Apr 20, 2021 | Merck |
| NCT04738487 | Phase 3 | Apr 7, 2021 | Merck |
| NCT04305054 | Phase 1/Phase 2 (Phase 2) | Jul 3, 2020 | Merck |
| NCT04305041 | Phase 1/Phase 2 (Phase 2) | Jul 3, 2020 | Merck |
| NCT04303169 | Phase 1/Phase 2 (Phase 2) | Jul 3, 2020 | Merck |
| NCT04165070 | Phase 2 | Jan 17, 2020 | Merck |
| NCT02964013 | Phase 1 | Dec 13, 2016 | Merck |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 14 | 14 | 3 | 2016 |
1 organizations
Page 1 / 1